Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPULsKF: Urate-lowering Therapy in Gout/CKD
NCT03336203Phase 4Unknown
- Sponsor
- Medical Practice Prof. D. Ivanov
- Start
- Oct 2017
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of allopurinol, febuxostat in hyperuricemia, gout, chronic kidney disease (CKD), sponsored by Medical Practice Prof. D. Ivanov. Status: unknown.
02
Drugs
allopurinolfebuxostat
03
Conditions
hyperuricemiagoutchronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT03336203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03336203.